For example, CRC-acquired superenhancers are closely associated with oncogenes and enriched with TCF4/LEF1-binding motifs; TCF4/LEF1 are the terminal TFs involved in the oncogenic Wnt/β-catenin signaling pathway104. This evidence concerns the gene TCF4 and colorectal carcinoma.